PHIO Phio Pharmaceuticals
- 0.8364
- -0.0429-4.88%
- 0.8600
- +0.0236+2.82%
Phio Pharmaceuticals News
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
MARLBOROUGH, Mass., April 30, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL siRNA gene silencing technology is d
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transactio
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to
Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
Phio Pharmaceuticals Corp (NASDAQ:PHIO) shares are trading higher after the company announced it is presenting new data about its lead clinical product candidate, PH-762, an INTASYL compound.The share
Express News | Phio Pharmaceuticals Shares Are Trading Higher After the Company Announced That Its Intratumoral Injection of Murine PH-762 Inhibited Tumor Growth in Murine Tumor Models and May Generate Memory-specific T Cells
Express News | Phio Pharmaceuticals Corp - Injection in Murine Tumors Shows Compound Is Well Tolerated
Express News | Intratumoral Injection of Phio’s Ph-762 Significantly Inhibits Tumor Growth in Murine Tumor Models and May Generate Memory-Specific T Cells
Intratumoral Injection of Phio's PH-762 Significantly Inhibits Tumor Growth in Murine Tumor Models and May Generate Memory-specific T Cells
-Injection in murine tumors shows the compound is well tolerated-Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinomaMARL
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
MARLBOROUGH, Mass., April 16, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL siRNA gene silencing technology is d
Express News | Phio Pharmaceuticals Announces Upcoming Presentation at the 27TH Annual Meeting of the American Society of Cell and Gene Therapy (Ascgt)
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
MARLBOROUGH, Mass., April 11, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL siRNA gene silencing technology is d
Express News | Phio Pharmaceuticals Announced Its INTASYL Platform Will Be The Focus Of Viewpoint, A National Program Hosted By Dennis Quaid
Phio Pharmaceuticals on the Brink: Nasdaq Delisting Looms Over Falling Stock Prices
National Spotlight Features Phio's Innovative RNAi Technology Platform
-Program will be airing on PBS with Dennis Quaid in April-It will also be seen on Fox Business NetworkMARLBOROUGH, Mass., April 03, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO),
Express News | Phio Pharma Q4 EPS $(0.17) May Not Be Comparable To $(1.30) Estimate; Cash Balance Of $8.5M
Phio Pharmaceuticals 2023 Loss/Shr $5.20 >PHIO
Phio Pharmaceuticals 2023 Loss/Shr $5.20 >PHIO
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersYield10 Bioscience (NASDAQ:YTEN) shares moved upwards by 71.5% to $0.42 during Thursday's regular session. The market value of their outstanding shares is at $4.9 million. Monogram Orthopaedics
PHIO and MGRM Among Healthcare Movers
Analysis
Price Target
No Data
